|
|
Volumn 19, Issue 1, 2004, Pages 3-
|
|
Levamisole (Decaris®) treatment during pregnancy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LEVAMISOLE;
ANTINEMATODAL AGENT;
TERATOGENIC AGENT;
ASCARIASIS;
ASCARIS LUMBRICOIDES;
BIRTH WEIGHT;
CONFIDENCE INTERVAL;
CRYPTORCHISM;
DATA ANALYSIS;
DRUG EFFECT;
DRUG INFORMATION;
EVALUATION;
EXPERIMENT;
GESTATIONAL AGE;
GROWTH RETARDATION;
HEALTH SURVEY;
HUMAN;
IMPLANTATION;
LETTER;
NEURAL TUBE DEFECT;
NONHUMAN;
PATIENT;
POPULATION RESEARCH;
PREGNANCY;
RISK ASSESSMENT;
STUDENT T TEST;
SYNDACTYLY;
TERATOGENICITY;
ADULT;
ANIMAL;
CASE CONTROL STUDY;
CLASSIFICATION;
CONGENITAL MALFORMATION;
FEMALE;
RABBIT;
RAT;
ASCARIS;
ASCARIS LUMBRICOIDES;
ABNORMALITIES, DRUG-INDUCED;
ADULT;
ANIMALS;
ANTINEMATODAL AGENTS;
CASE-CONTROL STUDIES;
FEMALE;
HUMANS;
LEVAMISOLE;
PREGNANCY;
RABBITS;
RATS;
RISK ASSESSMENT;
TERATOGENS;
|
|
EID: 4444357791
PISSN: 08906238
EISSN: None
Source Type: Journal
DOI: 10.1016/j.reprotox.2004.05.009 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
